Diagnostic manual
Category C diseases
Marteilia refringens, Bonamia ostreae and Bonamia exitiosa
The following section provides recommendations on the methods to be used for the diagnosis of category C diseases (endemic) and links to corresponding SOPs.
1. General rules
Reference : Commission Delegated Regulation (EU) 2020/689 describes the rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases, Annexe VI provides specific requirement as regards diseases of aquatic animal.
- For surveillance programme / granting or maintaining free status
- Histopathology, or tissue imprints or PCR
- To confirm of rule out suspicion
- Histopathology, or tissue imprints or in situ Hybridization (ISH) AND PCR & sequencing
- If no material for histopathology, or tissue imprints or ISH available: 2 PCR assays targeting different fragments of the genome & sequencing
2. Recommended methods
Reference: Commission Implementing Decision (EU) 2015/1554 of 11 September 2015 laying down rules for the application of Directive 2006/88/EC as regards requirements for surveillance and diagnostic methods and up-dates
Marteilia refringens | SOP |
Histopathology | |
Cytology | |
In Situ Hybridization M. refringens– Probe M2A / M3AS, Le Roux et al. 2001 (ITS1) | |
Conventional PCR M. refringens, Le Roux et al. 2001, Primers M2A & M3AS also named Pr4 & Pr5 (ITS1- 412bp). Type discrimination possible by RFLP. | |
Taqman real-time PCR M. refringens / Bonamia sp., Canier et al. 2020 (18S) | |
Taqman real-time PCR M. refringens type M / type O, EURL unpusblished (ITS1) | |
Recommended regions for sequencing: 18S and ITS1 |
Bonamia ostreae and Bonamia exitiosa | SOP |
Histopathology | |
Cytology | |
In Situ Hybridization Bonamia sp - Probe BO / BOAS, Cochennec et al. 2000 (18S) | |
Conventionnal PCR Bonamia sp., Cochennec et al. 2000, primers BO/BOAS (18S - 304bp). Species discrimination possible by RFLP | |
SYBR Green PCR B. ostreae / B. exitiosa, Ramilo et al. 2013, primers BOSTRE-F/R BEXIT F/R (ITS -18S) | Not available |
Taqman real-time PCR M. refringens / Bonamia sp., Canier et al. 2020 (18S) | |
Taqman real-time PCR B.ostreae/ B.exitiosa, EURL unpusblished (Actin) | |
Recommended regions for sequencing: 18S and Actin |
Category A diseases
The following section provides recommendations on the methods to be used for the diagnosis of category A diseases (exotic) and links to corresponding SOPs. Those recommendations are based on the the OIE (World Organisation for Animal Health) Manual of diagnostic Test for Aquatic Animals and EURL expertise.
Perkinsus marinus
1. General rules
- for surveillance programme / granting or maintaining free status
- Histopathology, or Ray’s Fluid Thioglycolate Medium (RFTM) culture or PCR
- To confirm of rule out suspicion
- Histopathology, or Ray’s Fluid Thioglycolate Medium (RFTM) or in situ Hybridization (ISH) AND PCR & sequencing ITS
2. Recommended methods
Perkinsus marinus | SOP |
Histopathology | |
Ray’s Fluid Thioglycolate Medium (RFTM) culture | |
In Situ Hybrization P. marinus, Probe PmarLSU-181DIG, Moss et al. 2006 (LSU) | |
SYBR Green PCR P. Marinus, Audemard et al. 2004, Primers PmarITS-70F & PmarITS600R (ITS-509bp) |
Mikrocytos mackini
1. General rules
- For surveillance programme / granting or maintaining free status
- Histopathology or PCR
- To confirm of rule out suspicion
- Histopathology or in situ Hybridization (ISH) AND PCR & sequencing on ITS + 18S
2. Recommended methods
Mikrocytos mackini | SOP |
Histopathology | |
In Situ Hybrization M. mackini, Probe MACKINI-1 F&R, Meyer et al. 2005 (18S) | |
Conventional PCR M. mackini, Carnegie et al. 2003, Primers MIKROCYTOS-F&R (18S-546 bp ) | |
Taqman Real Time PCR M. mackini, Polinski et al., 2015 (ITS2) |